Genetic Testing Market- Global Forecast To 2023

Genetic Testing Market- Global Forecast To 2023

ID: MRFR/HC/1477-CRR | June, 2017 | Region: Global | 140 pages | Cooked Research Reports

Global Genetic testing Market information, by Type (prescribed genetic testing, & DTC genetic testing), by Method (Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test), by Type of test (Diagnostic Test, Predictive Test, Family DNA Test, and others), by Indication (Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others) - Forecast to 2023


 


FIGURE 1                   GLOBAL GENETIC TESTING MARKET SHARE, BY TYPE (%)


 


Intended Audience



  • Genetic testing products manufacturers and suppliers

  • Genetic testing services providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Government authorities

  • Market Research and Consulting Service Providers

  • Potential Investors



Research Methodology:




 Sources: Directorate of Industries, Annual report, White paper, Company Presentation


 


Market Synopsis of Global Genetic testing Market:


Market Scenario:


Genetic testing involves the use of laboratory methods to study the genes inherited from mother or father. These tests may be used to identify increased risks of health problems, to diagnose the mutations in the genes, to choose treatments, or to assess responses to treatment.


The Global Genetic testing market is growing moderately. It is growing at the CAGR of ~9.8% during the forecast period. The global genetic testing market expected to reach USD 10,033.4 million by 2023 from USD 4,683 in 2016.



Segments:                                                                                                                                        


Global genetic testing market has been segmented on the basis of type which prescribed genetic testing, and direct to consumer (DTC) genetic testing. Prescribed Genetic Testing accounted for the largest market share in 2016. On the basis of method, it is segmented into Molecular Genetic Test/ DNA Test, Chromosomal Genetic Test, Biochemical Genetic Test. Molecular Genetic tests/DNA was holding largest market share in 2016. On the basis of type of test, the market is segmented into Diagnostic Test, Predictive Test, Family DNA Test, and others. Diagnostic test accounted for the largest market share in 2016. On the basis of indication it is segmented into Cancer Testing, Neurogenetic Disorder Testing, Autoimmune Disorder Testing, Muscular dystrophies, and others. Cancer Testing accounted for the largest market share in 2016.


Regional Analysis of Global Genetic Testing Market:                


Considering the global scenario of the market, due to continuous innovation, high awareness about the genetic testing and rapid adoption of new technology, Americas is largest market and was holding 46.3% market share of global Genetic testing in 2016. US is holding largest market share in North America region. European genetic testing market is expected to reach USD 2,553.10 million by 2023. On the other hand, due to increasing aging population and advances in the medical fields, the Asia-Pacific (APAC) is fastest growing market for Genetic testing and expected to grow at a CAGR of 10.1% during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness and lack of required infrastructure. 


Key Players for Global Genetic Testing Market:                                         


Some of the key players in this market are: Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), Illumina Inc. (US), Myriad Genetics (US), PerkinElmer Inc. (US), QIAGEN N.V. (Germany), and Quest Diagnostics (US)


The report for global genetic testing market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5.1 Porters Five Forces

6.1 Prescribed Genetic Testing

6.2 Direct to consumer Genetic Testing

7.1 Molecular Genetic Test/ DNA Test

7.1.1 Direct Sequencing

7.1.2 PCR

7.1.3 Hybridization

7.1.4 Comparative genomic hybridization

7.1.5 DNA microarray analysis

7.1.6 Others

7.2 Chromosomal Genetic Test

7.2.1 FISH

7.2.2 Others

7.3 Biochemical Genetic Test

7.3.1 HPLC

7.3.2 Gas Chromatography/ Mass Spectrometry

7.3.3 Tandem Mass Spectrometry

8.1 Diagnostic Test

8.2 Predictive Test

8.3 Family DNA Test

8.4 Others

9.1 Cancer Testing

9.2 Neurogenetic Disorder Testing

9.3 Autoimmune Disorder Testing

9.4 Muscular dystrophies

9.5 Others

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 The US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.3 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia

10.4.1 China

10.4.2 India

10.4.3 Japan

10.4.4 South Korea

10.4.5 Rest of Asia

10.5 Pacific

10.6 Middle East and Africa

10.6.1 UAE

10.6.2 Saudi Arabia

10.6.3 Egypt

10.6.4 Rest of Middle East and Africa

10. Competitive landscape

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product/Business Segment Overview

11.1.3 Financial Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Company Overview

11.2.2 Product/Business Segment Overview

11.2.3 Financial Overview

11.2.4 Key Development

11.2.5 SWOT Analysis

11.3 Illumina Inc.

11.3.1 Company Overview

11.3.2 Product/Business Segment Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.1.5 SWOT Analysis

11.4 Myriad Genetics

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Strategy:

11.4.5 SWOT Analysis

11.5 PerkinElmer Inc.

11.6.1 Company Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Overview

11.6.4 Key Development

11.6.5 SWOT Analysis

11.6 QIAGEN N.V.

11.6.1 Company Overview

11.6.2 Product/Business Segment Overview

11.6.3 Financial Overview

11.6.4 Key Development

11.1.5 SWOT Analysis

11.7 Quest Diagnostics

11.7.1 Company Overview

11.7.2 Product/Business Segment Overview

11.7.3 Financial Overview

11.7.4 Key Development

11.7.5 SWOT Analysis

TABLE 1 GLOBAL GENETIC TESTING MARKET BY TYPE, 2014 TO 2023 (USD MILLION) 28
TABLE 2 GLOBAL PRESCRIBED GENETIC TESTING MARKET, 2014 TO 2023 (USD MILLION) 29
TABLE 3 GLOBAL DIRECT TO CONSUMER GENETIC TESTING MARKET, 2014 TO 2023 (USD MILLION) 30
TABLE 4 GLOBAL GENETIC TESTING MARKET BY METHOD, 2014 TO 2023 (USD MILLION) 31
TABLE 5 GLOBAL MOLECULAR GENETIC TESTS/ DNA TEST MARKET, 2014 TO 2023 (USD MILLION) 32
TABLE 6 GLOBAL CHROMOSOMAL GENETIC TEST MARKET, 2014 TO 2023 (USD MILLION) 33
TABLE 7 GLOBAL BIOCHEMICAL GENETIC TEST MARKET, 2014 TO 2023 (USD MILLION) 34
TABLE 8 GLOBAL GENETIC TESTING MARKET BY TYPE OF TEST, 2014 TO 2023 (USD MILLION) 36
TABLE 9 GLOBAL DIAGNOSTIC TEST MARKET, 2014 TO 2023 (USD MILLION) 37
TABLE 10 GLOBAL PREDICTIVE TEST MARKET, 2014 TO 2023 (USD MILLION) 38
TABLE 11 GLOBAL FAMILY DNA TEST MARKET, 2014 TO 2023 (USD MILLION) 38
TABLE 12 GLOBAL GENETIC TESTING MARKET BY INDICATION, 2014 TO 2023 (USD MILLION) 41
TABLE 13 GLOBAL GENETIC TESTING MARKET FOR CANCER TESTING, 2014 TO 2023 (USD MILLION) 42
TABLE 14 GLOBAL GENETIC TESTING MARKET FOR NEUROGENETIC DISORDER TESTING, 2014 TO 2023 (USD MILLION) 42
TABLE 15 GLOBAL GENETIC TESTING MARKET FOR AUTOIMMUNE DISORDER TESTING, 2014 TO 2023 (USD MILLION) 43
TABLE 16 GLOBAL GENETIC TESTING MARKET FOR MUSCULAR DYSTROPHIES, 2014 TO 2023 (USD MILLION) 44
TABLE 17 GLOBAL GENETIC TESTING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 45
TABLE 18 AMERICAS GENETIC TESTING MARKET BY COUNTRY, 2014 TO 2023 (USD MILLION) 47
TABLE 19 AMERICAS GENETIC TESTING MARKET, BY TYPE (USD MILLION) 47
TABLE 20 AMERICAS GENETIC TESTING MARKET, BY METHOD (USD MILLION) 48
TABLE 21 AMERICAS GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 48
TABLE 22 AMERICAS GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 49
TABLE 23 NORTH AMERICA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 50
TABLE 24 NORTH AMERICA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 50
TABLE 25 NORTH AMERICA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 51
TABLE 26 NORTH AMERICA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 51
TABLE 27 U.S. GENETIC TESTING MARKET, BY TYPE (USD MILLION) 52
TABLE 28 U.S. GENETIC TESTING MARKET, BY METHOD (USD MILLION) 52
TABLE 29 U.S. GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 53
TABLE 30 U.S. GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 53
TABLE 31 CANADA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 54
TABLE 32 CANADA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 54
TABLE 33 CANADA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 55
TABLE 34 CANADA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 55
TABLE 35 SOUTH AMERICA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 56
TABLE 36 SOUTH AMERICA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 56
TABLE 37 SOUTH AMERICA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 57
TABLE 38 SOUTH AMERICA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 57
TABLE 39 EUROPE GENETIC TESTING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 59
TABLE 40 EUROPE GENETIC TESTING MARKET, BY TYPE (USD MILLION) 59
TABLE 41 EUROPE GENETIC TESTING MARKET, BY METHOD (USD MILLION) 60
TABLE 42 EUROPE GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 60
TABLE 43 EUROPE GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 61
TABLE 44 WESTERN EUROPE GENETIC TESTING MARKET, BY TYPE (USD MILLION) 62
TABLE 45 WESTERN EUROPE GENETIC TESTING MARKET, BY METHOD (USD MILLION) 62
TABLE 46 WESTERN EUROPE GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 63
TABLE 47 WESTERN EUROPE GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 63
TABLE 48 GERMANY GENETIC TESTING MARKET, BY TYPE (USD MILLION) 64
TABLE 49 GERMANY GENETIC TESTING MARKET, BY METHOD (USD MILLION) 64
TABLE 50 GERMANY GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 65
TABLE 51 GERMANY GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 65
TABLE 52 FRANCE GENETIC TESTING MARKET, BY TYPE (USD MILLION) 66
TABLE 53 FRANCE GENETIC TESTING MARKET, BY METHOD (USD MILLION) 66
TABLE 54 FRANCE GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 67
TABLE 55 FRANCE GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 67
TABLE 56 U.K. GENETIC TESTING MARKET, BY TYPE (USD MILLION) 68
TABLE 57 U.K. GENETIC TESTING MARKET, BY METHOD (USD MILLION) 68
TABLE 58 U.K. GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 69
TABLE 59 U.K. GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 69
TABLE 60 ITALY GENETIC TESTING MARKET, BY TYPE (USD MILLION) 70
TABLE 61 ITALY GENETIC TESTING MARKET, BY METHOD (USD MILLION) 70
TABLE 62 ITALY GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 71
TABLE 63 ITALY GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 71
TABLE 64 SPAIN GENETIC TESTING MARKET, BY TYPE (USD MILLION) 72
TABLE 65 SPAIN GENETIC TESTING MARKET, BY METHOD (USD MILLION) 72
TABLE 66 SPAIN GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 73
TABLE 67 SPAIN GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 73
TABLE 68 REST OF WESTERN EUROPE GENETIC TESTING MARKET, BY TYPE (USD MILLION) 74
TABLE 69 REST OF WESTERN EUROPE GENETIC TESTING MARKET, BY METHOD (USD MILLION) 74
TABLE 70 REST OF WESTERN EUROPE GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 75
TABLE 71 REST OF WESTERN EUROPE GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 75
TABLE 72 EASTERN EUROPE GENETIC TESTING MARKET, BY TYPE (USD MILLION) 76
TABLE 73 EASTERN EUROPE GENETIC TESTING MARKET, BY METHOD (USD MILLION) 76
TABLE 74 EASTERN EUROPE GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 77
TABLE 75 EASTERN EUROPE GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 77
TABLE 76 ASIA-PACIFIC GENETIC TESTING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 79
TABLE 77 ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE (USD MILLION) 79
TABLE 78 ASIA-PACIFIC GENETIC TESTING MARKET, BY METHOD (USD MILLION) 80
TABLE 79 ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 80
TABLE 80 ASIA-PACIFIC GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 81
TABLE 81 JAPAN GENETIC TESTING MARKET, BY TYPE (USD MILLION) 81
TABLE 82 JAPAN GENETIC TESTING MARKET, BY METHOD (USD MILLION) 82
TABLE 83 JAPAN GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 82
TABLE 84 JAPAN GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 83
TABLE 85 CHINA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 83
TABLE 86 CHINA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 84
TABLE 87 CHINA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 84
TABLE 88 CHINA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 85
TABLE 89 INDIA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 85
TABLE 90 INDIA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 86
TABLE 91 INDIA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 86
TABLE 92 INDIA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 87
TABLE 93 REPUBLIC OF KOREA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 87
TABLE 94 REPUBLIC OF KOREA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 88
TABLE 95 REPUBLIC OF KOREA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 88
TABLE 96 REPUBLIC OF KOREA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 89
TABLE 97 AUSTRALIA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 89
TABLE 98 AUSTRALIA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 90
TABLE 99 AUSTRALIA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 90
TABLE 100 AUSTRALIA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 91
TABLE 101 REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE (USD MILLION) 91
TABLE 102 REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY METHOD (USD MILLION) 92
TABLE 103 REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 92
TABLE 104 REST OF ASIA-PACIFIC GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 93
TABLE 105 MIDDLE EAST & AFRICA GENETIC TESTING MARKET BY REGION, 2014 TO 2023 (USD MILLION) 94
TABLE 106 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 94
TABLE 107 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 95
TABLE 108 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 95
TABLE 109 MIDDLE EAST & AFRICA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 96
TABLE 110 MIDDLE EAST GENETIC TESTING MARKET, BY TYPE (USD MILLION) 96
TABLE 111 MIDDLE EAST GENETIC TESTING MARKET, BY METHOD (USD MILLION) 97
TABLE 112 MIDDLE EAST GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 97
TABLE 113 MIDDLE EAST GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 98
TABLE 114 AFRICA GENETIC TESTING MARKET, BY TYPE (USD MILLION) 98
TABLE 115 AFRICA GENETIC TESTING MARKET, BY METHOD (USD MILLION) 99
TABLE 116 AFRICA GENETIC TESTING MARKET, BY TYPE OF TEST (USD MILLION) 99
TABLE 117 AFRICA GENETIC TESTING MARKET, BY INDICATION (USD MILLION) 100
TABLE 118 GLOBAL GENETIC TESTING MARKET: MERGER & ACQUISITION 101
TABLE 119 GLOBAL GENETIC TESTING MARKET: AGREEMENT/PARTNERSHIP & COLLABORATIONS 102
TABLE 120 GLOBAL GENETIC TESTING MARKET: NEW PRODUCT /SERVICE LAUNCH 103
TABLE 121 GLOBAL GENETIC TESTING MARKET: OTHER DEVELOPMENT 105
TABLE 122 ABBOTT LABORATORIES: KEY DEVELOPMENTS 108
TABLE 123 BIO-RAD LABORATORIES: KEY DEVELOPMENT 112
TABLE 124 ILLUMINA INC: KEY DEVELOPMENT 116
TABLE 125 MYRIAD GENETICS: KEY DEVELOPMENT 120
TABLE 126 PERKIN ELMER KEY DEVELOPMENT 124
TABLE 127 QIAGEN: KEY DEVELOPMENT 126
TABLE 128 QUEST DIAGNOSTICS: KEY DEVELOPMENT 130

FIGURE 1 GLOBAL GENETIC TESTING MARKET SHARE, BY TYPE, 2016 (%) 13
FIGURE 2 GLOBAL GENETIC TESTING MARKET SHARE, BY METHOD, 2016 (%) 14
FIGURE 3 GLOBAL GENETIC TESTING MARKET SHARE, BY TYPE OF TEST, 2016 (%) 14
FIGURE 4 GLOBAL GENETIC TESTING MARKET SHARE, BY INDICATION, 2016 (%) 15
FIGURE 5 GLOBAL GENETIC TESTING MARKET SHARE, BY REGION, 2016 (%) 16
FIGURE 6 MARKET STRUCTURE OF GLOBAL GENETIC TESTING MARKET 18
FIGURE 7 RESEARCH PROCESS OF MRFR 19
FIGURE 8 GLOBAL GENETIC TESTING MARKET FORECAST INDICATORS 21
FIGURE 9 PORTERS FIVE FORCES MODEL 25
FIGURE 10 GLOBAL GENETIC TESTING MARKET BY TYPE, 2016 & 2023 (USD MILLION) 28
FIGURE 11 GLOBAL GENETIC TESTING MARKET BY METHOD, 2016 & 2023 (USD MILLION) 31
FIGURE 12 GLOBAL GENETIC TESTING MARKET BY TYPE OF TEST, 2016 & 2023 (USD MILLION) 35
FIGURE 13 GLOBAL GENETIC TESTING MARKET BY INDICATION, 2016 & 2023 (USD MILLION) 40
FIGURE 14 GLOBAL GENETIC TESTING MARKET BY REGION, 2016 (%) 45
FIGURE 15 AMERICAS GENETIC TESTING MARKET BY REGION, 2016 (%) 46
FIGURE 16 NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY, 2016 (%) 49
FIGURE 17 EUROPE GENETIC TESTING MARKET BY REGION, 2016 (%) 58
FIGURE 18 WESTERN EUROPE GENETIC TESTING MARKET BY COUNTRY, 2016 (%) 61
FIGURE 19 ASIA-PACIFIC GENETIC TESTING MARKET BY REGION, 2016 (%) 78
FIGURE 20 MIDDLE EAST & AFRICA GENETIC TESTING MARKET BY REGION, 2016 (%) 94
FIGURE 21 ABBOTT LABORATORIES: RECENT FINANCIALS (USD MILLION) 107
FIGURE 22 ABBOTT LABORATORIES: GEOGRAPHICAL REVENUE, 2016 (%) 107
FIGURE 23 ABBOTT LABORATORIES: SEGMENTAL REVENUE, 2016 (%) 108
FIGURE 24 ABBOTT LABORATORIES: SWOT ANALYSIS 109
FIGURE 25 BIO-RAD LABORATORIES: RECENT FINANCIALS 111
FIGURE 26 BIO-RAD LABORATORIES: GEOGRAPHICAL MIX, 2016 (%) 111
FIGURE 27 BIO-RAD LABORATORIES: SEGMENT MIX, 2016 (%) 112
FIGURE 28 BIO-RAD LABORATORIES: SWOT ANALYSIS 113
FIGURE 29 ILLUMINA INC.: RECENT FINANCIALS 115
FIGURE 30 ILLUMINA INC: GEOGRAPHICAL MIX, 2016 (%) 115
FIGURE 31 ILLUMINA INC: SEGMENTAL MIX, 2016 (%) 116
FIGURE 32 ILLUMINA INC: SWOT ANALYSIS 117
FIGURE 33 MYRIAD GENETICS INC: RECENT FINANCIALS 119
FIGURE 34 MYRIAD GENETICS INC: SEGMENT REVENUE, 2016 (%) 119
FIGURE 35 MYRIAD GENETICS: SWOT ANALYSIS 121
FIGURE 36 PERKIN ELMER RECENT FINANCIALS 122
FIGURE 37 PERKIN ELMER GEOGRAPHIC MIX, 2016 (%) 123
FIGURE 38 PERKIN ELMER SEGMENT MIX, 2016 (%) 123
FIGURE 39 PERKIN ELMER SWOT ANALYSIS 124
FIGURE 40 QIAGEN N.V.: RECENT FINANCIALS 125
FIGURE 41 QIAGEN N.V.: SEGMENT MIX, 2016 (%) 126
FIGURE 42 QIAGEN N.V.: GEOGRAPHIC MIX, 2016 (%) 126
FIGURE 43 QIAGEN N.V.: SWOT ANALYSIS 127
FIGURE 44 RECENT FINANCIALS 129
FIGURE 45 SEGMENTAL REVENUE, 2016 (%) 129
FIGURE 46 QUEST DIAGNOSTICS: SWOT ANALYSIS 131